Related Experiment Video
Updated: Oct 1, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Immunological and anti-viral therapy of chronic hepatitis B virus infection
Abstract:
Although we have reached the stage when we can influence viral replication and some aspects of the immune response to the viral antigens, no practical and effective therapeutic regimen has been evolved. The next few years should, however, see considerable advances in this field, perhaps with combined anti-viral and immunostimulant regimens. The need to consider the infectivity of the patient, the risk of developing clinically significant chronic liver disease and the risk of developing clinically significant chronic liver disease and the risk of developing primary liver cell carcinoma in each patient may dictate that different regimens will be needed for HBe antigen-positive and negative carriers and for patients with chronic active or chronic persistent hepatitis and carriers with normal liver histology.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Retrovirus Life Cycles
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatitis
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Viral Hepatitis I: Introduction